KRYS vs TYL · P/E 46, rev $235.6M vs P/E 89, rev $1.26B
Krystal Biotech Inc (KRYS) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the KRYS and TYL stock pages for the full models.
Not investment advice.